Analyst consensus rating
Eloxx Pharmaceuticals Analyst Rating: none
Direct answer
Eloxx Pharmaceuticals's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $37.50.
Forecast evidence checked November 12, 2026.
Get free Eloxx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.01
- Average price target
- $37.50
- High price target
- $40.00
- Low price target
- $32.00
- Low target gap
- +146%
- Target upside
- +188.2%
- High target gap
- +207.5%
- Target range width
- 61.5%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $37.50.
How far are Eloxx Pharmaceuticals's low and high targets from the recorded price?
The low target implies +146%, while the high target implies +207.5%.
How many analysts are included in Eloxx Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is Eloxx Pharmaceuticals's target upside or downside calculated?
The average target of $37.50 is divided by the recorded price of $13.01, then one is subtracted to produce +188.2%. This does not guarantee a future return.
When was Eloxx Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.